Home / BALPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does BALPHARMA.NS make money? Does BALPHARMA.NS have pricing power? What's the Earnings Whisper? Will BALPHARMA.NS profit more as the business scales? What is BALPHARMA.NS's management track record? Is BALPHARMA.NS's current price justified?

Bal Pharma Limited

₹95.75 +$22.73 (+31.13%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹97.74

Day Range

₹95.15₹99

Year Range

₹60₹124.6

Market Cap

1.52B

AVG Volume

63.57K

Trailing/Forward PE

21.09/-

PEG ratio

-3.4

Dividend Yield

1.25%

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

BALPHARMA.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	886.16M
26 Q4	840.76M
26 Q3	876.9M
26 Q2	740.25M
26 Q1	658.71M
25 Q4	818.76M
25 Q3	731.54M
25 Q2	736.94M
25 Q1	743.59M
24 Q4	946.26M

Net Income (INR) · Q

BALPHARMA.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	11.23M
26 Q4	35.93M
26 Q3	17.8M
26 Q2	7.09M
26 Q1	2.01M
25 Q4	54.34M
25 Q3	4.81M
25 Q2	10.42M
25 Q1	2.59M
24 Q4	54.73M

Operating Income (INR) · Q

BALPHARMA.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	51.66M
26 Q4	75.09M
26 Q3	63.15M
26 Q2	34.59M
26 Q1	35.4M
25 Q4	54.6M
25 Q3	50.73M
25 Q2	52.19M
25 Q1	40.38M
24 Q4	74.37M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Bal Pharma Limited

Video analysis: BALPHARMA.NS

News: BALPHARMA.NS

Similar companies